01 2Antares Pharma Inc.
02 5Antares Pharma, Inc
01 6No Action Indicated
02 1Voluntary Action Indicated
01 12018-12-04
02 12017-02-27
03 22016-01-21
04 12012-09-06
05 12012-08-20
06 12009-07-14
01 2Ewing
02 5Minneapolis
01 7US
District Decision : No Action Indicated
Inspection End Date : 2012-08-20
City : Ewing
State : NJ
Country/Area : US
Zip : 08618-1433
District : NWJ
Center : CDRH
Project Area : Compliance: Devices
District Decision : No Action Indicated
Inspection End Date : 2012-08-20
District Decision : No Action Indicated
Inspection End Date : 2017-02-27
City : Ewing
State : NJ
Country/Area : US
Zip : 08618-1433
District : NWJ
Center : CDER
Project Area : Postmarket Surv. and Epidemiolog...
District Decision : No Action Indicated
Inspection End Date : 2017-02-27
District Decision : No Action Indicated
Inspection End Date : 2009-07-14
City : Minneapolis
State : MN
Country/Area : US
Zip : 55447-5473
District : MIN
Center : CDRH
Project Area : Compliance: Devices
District Decision : No Action Indicated
Inspection End Date : 2009-07-14
District Decision : No Action Indicated
Inspection End Date : 2012-09-06
City : Minneapolis
State : MN
Country/Area : US
Zip : 55447-5473
District : MIN
Center : CDRH
Project Area : Compliance: Devices
District Decision : No Action Indicated
Inspection End Date : 2012-09-06
District Decision : No Action Indicated
Inspection End Date : 2016-01-21
City : Minneapolis
State : MN
Country/Area : US
Zip : 55447-5473
District : MIN
Center : CDRH
Project Area : Compliance: Devices
District Decision : No Action Indicated
Inspection End Date : 2016-01-21
District Decision : No Action Indicated
Inspection End Date : 2016-01-21
City : Minneapolis
State : MN
Country/Area : US
Zip : 55447-5473
District : MIN
Center : CDRH
Project Area : Postmarket Assurance: Devices
District Decision : No Action Indicated
Inspection End Date : 2016-01-21
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-12-04
City : Minneapolis
State : MN
Country/Area : US
Zip : 55447-5473
District : MIN
Center : CDRH
Project Area : Compliance: Devices
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-12-04
Halozyme Therapeutics is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of ENHANZE DRUG PRODUCT bulk with DMF offered by Halozyme Therapeutics
LOOKING FOR A SUPPLIER?